| Name | Title | Contact Details |
|---|
Retirement Concepts is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Applied Reimbursement Techniques is a Mobile, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AZTherapies, Inc. is a private, late-stage clinical biopharmaceutical company developing treatments for devastating neurological conditions.
Teladoc, Inc. (NYSE: TDOC) is re-defining how Americans access quality healthcare. We are the largest and most trusted provider of virtual care delivery in the world, with an innovative, comprehensive portfolio of virtual care solutions that works across the healthcare ecosystem to provide a new kind of connected healthcare experience, one with better convenience, quality and value. We partner with a diverse group of customers who share our passion and our vision for improving the overall delivery of care. From payers to providers to employers and consumers, we provide services and solutions that marry data & analytics, devices & wearables and ubiquitous access points with a highly relevant, engaging consumer experience. Having completed more than 2.5 million medical consults, our commitment to driving patient engagement is proven to change behavior, delivering unmatched cost savings, productivity and presenteeism. Recognized by MIT Technology Review as one of the “50 Smartest Companies,” we provide a single solution for clients and members to seamlessly, virtually access the full spectrum of healthcare needs through our diverse portfolio of brands: • Teladoc provides quality care for a range of non-urgent medical conditions via our 3000+ board certified physicians and therapists 24/7/365 via web, phone, or award winning mobile app • Best Doctors connects individuals facing difficult diagnostic or medical treatment decisions with expert medical consultation focused on improving health outcomes for the most complex, critical and costly medical issues • Healthiest You delivers an innovative consumer engagement experience platform designed to redirect claims and improve access to care • Better Help is the leader in direct-to-consumer virtual therapy, offering convenient, affordable, private counseling • TeladocHSS, an innovative cloud-based telehealth solution purpose built to address the complex needs of hospitals and health systems.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.